FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label -- INDIANAPOLIS, June 8, 2011 /PRNewswire/ --
Links shared publicly online about this topic.
- 234total visits
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label -- INDIANAPOLIS, June 8, 2011 /PRNewswire/ --
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label. Update for Insulin Pump Use Provides an Additional Option for Children With Type 1 Diabetes and Extends Amount of Time People Can Use and Store Humalog Insulin in Their Pumps.
View full resource at prnewswire.com
Tags: Diabetes, Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Type 1 Diabetes, Children's Health, FDA, Humalog
Most Recently Shared on June 8, 2011 at 1:02 pm By:
Humalog OK'd in pumps for 7 days & for pumper kids 4+ with type 1 diabetes: http://prn.to/irk0tV
Advertisement
